Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02670187
Recruitment Status : Unknown
Verified January 2016 by GeneOne Life Science, Inc..
Recruitment status was:  Active, not recruiting
First Posted : February 1, 2016
Last Update Posted : July 27, 2016
Inovio Pharmaceuticals
Walter Reed Army Institute of Research (WRAIR)
Information provided by (Responsible Party):
GeneOne Life Science, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2017
  Estimated Study Completion Date : September 2017